| Literature DB >> 22577613 |
Le-Qian Hu1, Chun-Ling Yin, Ya-Hui Du, Zhi-Peng Zeng.
Abstract
A simple, rapid, and sensitive method for the simultaneous determination of vancomycin and cephalexin in human plasma was developed by using HPLC-DAD with second-order calibration algorithms. Instead of a completely chromatographic separation, mathematical separation was performed by using two trilinear decomposition algorithms, that is, PARAFAC-alternative least squares (PARAFAC-ALSs) and self-weight-alternative-trilinear-decomposition- (SWATLD-) coupled high-performance liquid chromatography with DAD detection. The average recoveries attained from PARAFAC-ALS and SWATLD with the factor number of 4 (N = 4) were 101 ± 5% and 102 ± 4% for vancomycin, and 96 ± 3% and 97 ± 3% for cephalexininde in real human samples, respectively. The statistical comparison between PARAFAC-ALS and SWATLD is demonstrated to be similar. The results indicated that the combination of HPLC-DAD detection with second-order calibration algorithms is a powerful tool to quantify the analytes of interest from overlapped chromatographic profiles for complex analysis of drugs in plasma.Entities:
Year: 2012 PMID: 22577613 PMCID: PMC3346993 DOI: 10.1155/2012/256963
Source DB: PubMed Journal: J Anal Methods Chem ISSN: 2090-8873 Impact factor: 2.193
Figure 1The structures of vancomycin and cephalexin.
Determination results of vancomycin and Cephalexin by HPLC-DAD using PARAFAC-ALS and SWATLD algorithm in human plasma (N = 4).
| Sample | Added | SWATLD | PARAFAC | |||
|---|---|---|---|---|---|---|
| Vanc | Cepd | Vanc | Cepd | Vanc | Cepd | |
| (mg/mL) | (mg/mL) | (mg/mL) | (mg/mL) | (mg/mL) | (mg/mL) | |
| 11 | 15.15 | 15.27 | 14.25 | 14.71 | 14.02 | 14.57 |
| 12 | 20.20 | 20.36 | 20.58 | 20.52 | 20.06 | 20.49 |
| 13 | 30.30 | 10.18 | 30.64 | 9.99 | 30.39 | 10.02 |
| 14 | 20.20 | 30.54 | 21.52 | 29.46 | 21.50 | 29.27 |
| 15 | 25.25 | 25.45 | 25.24 | 23.68 | 24.81 | 23.71 |
| 16 | 20.20 | 15.27 | 21.25 | 14.39 | 21.45 | 14.25 |
|
| ||||||
| 11 | 94.1% | 96.4% | 92.5% | 95.4% | ||
| 12 | 101.9% | 100.8% | 99.3% | 100.7% | ||
| 13 | 101.1% | 98.1% | 100.3% | 98.5% | ||
| 14 | 106.6% | 96.5% | 106.5% | 95.8% | ||
| 15 | 99.9% | 93.0% | 98.2% | 93.2% | ||
| 16 | 105.2% | 94.2% | 106.2% | 93.3% | ||
| MRa | 102 ± 4% | 97 ± 3% | 101 ± 5% | 96 ± 3% | ||
| RMSEPb | 0.0081 | 0.0095 | 0.0089 | 0.0102 | ||
aMean recovery.
bRoot mean square error of prediction.
cVancomycin.
dCephalexin.
Figure 2The results of factor-determining of the HPLC-DAD data arrays by CORCONDIA (a) and LTMC (b).
Figure 3Normalized chromatographic profiles were resolved by the SWATLD in human plasma. Solid and dotted lines represent the chromatographic profiles of vancomycin, cephalexin, and interference. The medium dash denotes the actual vancomycin and cephalexin.
Figure 4Normalized UV-Vis spectral profiles were resolved by the SWATLD in human plasma. Solid and dotted lines represent the UV-vis spectral profiles of vancomycin, cephalexin, and interference. The medium dash denotes the actual vancomycin and cephalexin.
Analytical figure of merit.
| SWALTD | PARAFAC | |||
|---|---|---|---|---|
| Figure of merita | Vancomycin | Cephalexin | Vancomycin | Cephalexin |
| Sensitivity (SEN), ABS, mL/mg | 1.009 | 1.920 | 0.8921 | 1.301 |
| Selectivity (SEL) | 0.105 | 0.235 | 0.102 | 0.238 |
| LOD, mg/mL | 0.32 | 0.047 | 0.12 | 0. 026 |
aABS is the absorption intensity (arbitrary units).